PartsTable
Technical Data Sheet
Download PDF

K5086-11 — CEFTAZIDIME FOR INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

K5086-11: CEFTAZIDIME FOR INJECTION.

The CEFTAZIDIME FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: POWDER, administration: INTRAMUSCULAR OR INTRAVENOUS, primary_container_type: VIAL, MULTIPLE DOSE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 6.000 GRAMS OF ACTIVE INGREDIENT G, active_medicament_medicinal_strength: 6.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-300-2115, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
K5086-11
NSN: 6505-01-300-2115
FSC: 6505 — Drugs and Biologicals
CAGE: 60060 — ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION (USA)
SPECIFICATIONS
physical_formPOWDER
administrationINTRAMUSCULAR OR INTRAVENOUS
special_featuresEACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 6 GRAMS OF CEFTAZIDIME,AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME; PHARMACY BULK PACK G
primary_container_typeVIAL, MULTIPLE DOSE
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
primary_container_content_quantity6.000 GRAMS OF ACTIVE INGREDIENT G
active_medicament_medicinal_strength6.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G
part_name_assigned_by_controlling_agencyCEFTAZIDIME FOR INJECTION
NSN6505-01-300-2115
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available CEFTAZIDIME FOR INJECTION TITLE COMPONENT PN K5086-11 MFR CEFTAZIDIME FOR INJECT
KEY FEATURES
•
ADMINISTRATION: INTRAMUSCULAR OR INTRAVENOUS
•
PRIMARY CONTAINER CONTENT QUANTITY: 6.000 GRAMS OF ACTIVE INGREDIENT G
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
•
PHYSICAL FORM: POWDER
•
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G
TECHNICAL CHARACTERISTICS
ADMINISTRATIONINTRAMUSCULAR OR INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY6.000 GRAMS OF ACTIVE INGREDIENT G
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPEVIAL, MULTIPLE DOSE
PHYSICAL FORMPOWDER
SPECIAL FEATURESEACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 6 GRAMS OF CEFTAZIDIME,AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME; PHARMACY BULK PACK G
PART NAME ASSIGNED BY CONTROLLING AGENCYCEFTAZIDIME FOR INJECTION
ACTIVE MEDICAMENT MEDICINAL STRENGTH6.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES

No substitute or cross-reference records for this part.

LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy K5086-11?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is K5086-11?
K5086-11 is a CEFTAZIDIME FOR INJECTION.
What is the NSN for K5086-11?
K5086-11 is cataloged in the U.S. Government catalog under NSN 6505-01-300-2115. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — K5086-11